Latest DiaTech Oncology Stories
Test Tailors Cancer Treatment Plan, Improves Outcomes and Lowers Chemo Costs Franklin, Tennessee (PRWEB) December 02, 2014 DiaTech Oncology, provider
WASHINGTON, Feb. 8, 2011 /PRNewswire/ -- DiaTech Oncology announced today they have engaged in a pilot with Walter Reed Army Medical Center to determine the best Chemotherapy for Cancer patients.
NASHVILLE, Tenn., May 26 /PRNewswire/ -- DiaTech Oncology announced today that the American Society of Cancer Oncology (ASCO) has published the results of a comprehensive study to determine the effectiveness of the Microculture Kinetic (MiCK) assay for apoptosis in predicting increased response and survival rates for ovarian cancer patients.
- A person in a secondary role, specifically the second most important character (after the protagonist).